U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040592) titled 'Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide' on June 12.
Brief Summary: This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an intervention consisting of off-label use of a medication with strong efficacy data for alcohol use disorder (AUD) with medical management and a clinical pharmacist-delivered behavioral intervention in reducing alcohol use among individuals with HIV and AUD.
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Alcohol Use Disorder (AUD)
HIV
Intervention:
DRUG: semaglutide
All participants will receive...